Current status of prognostic factors in patients with metastatic renal cell carcinoma

In recent years, the induction of novel agents, including molecular‐targeted agents and immune checkpoint inhibitors, have dramatically changed therapeutic options and their outcomes for metastatic renal cell carcinoma. Several prognostic models based on the data of patients with metastatic renal ce...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	International journal of urology 2019-06, Vol.26 (6), p.608-617
Hauptverfasser:	Teishima, Jun, Inoue, Shogo, Hayashi, Tetsutaro, Matsubara, Akio
Format:	Artikel
Sprache:	eng
Schlagworte:	biomarker C‐reactive protein metastatic renal cell carcinoma prognostic factor targeted therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!